Endocrine Abstracts

Abstract Unavailable....

Abstract Unavailable....

Abstract Unavailable....

Abstract Unavailable....

The management of neuroendocrine tumours involving the thoracic cavity has evolved over the past few years. However, there remains large variation in diagnosis, treatment and follow up of these patients. The lessons learnt from management of these tumours at other sites in the body have led to recommendation of radical resection of these tumours, while preserving the lung parenchyma. The surgical techniques for management of NET tumours and experience of Regional department of...

The predominant treatment modality for patients with bronchial neuro-endocrine tumours (excluding small cell lung cancer) is surgical. Despite this, disease can recur, in both local and metastatic form, even many years after treatment. The follow-up of patients after surgery should aim to improve clinical outcomes and avoid harm. Follow-up can be in the form of clinical review, biochemical tests and radiological imaging. The evidence base for the optimal form of follow up for ...

Well differentiated lung neuroendocrine tumours (WD lung NETS) are common NETs accounting for 25% of all the presenting neuroendocrine tumours. However, they are classified differently compared to GEP NETs, their mode of presentation; pattern of metastatic spread; associated syndromes, and how they respond to therapies are different from GEP NETs. They even present to a different group of specialists (respiratory physicians and thoracic surgeons) whereas the GEP NET patients t...